Original Article

Outcome and Survival in Patients with Stage II/III Sigmoid, Rectosigmoid and Upper Third Rectal Cancer Treated with Upfront Surgery
  • Cemal Ulusoy
  • Andrej Nikolovski
Eur Arc Med Res 2023; 39: 51-56 DOI: 10.4274/eamr.galenos.2023.99267
The Metastatic Lymph Node Ratio is a Crucial Criterion in Colorectal Cancer Therapy Management and Prognosis
  • Gülçin Harman Kamalı
  • Sedat Kamalı
Eur Arc Med Res 2022; 38: 73-79 DOI: 10.4274/eamr.galenos.2022.08769
Evaluation of Preoperative Carcinoembryonic Antigen Positivity in Relation to Volume-based PET/CT Parameters in Patients with Colorectal Cancer
  • Yunus Güzel
  • Cihan Gündoğan
  • Canan Can
Eur Arc Med Res 2021; 37: 162-166 DOI: 10.4274/eamr.galenos.2021.43255
The Efficacy of 18F-FDG PET/CT in Detecting Colorectal Cancer Recurrences
  • Aysun Küçüköz Uzun
  • Tülay Kaçar Güveli
  • Filiz Özülker
  • Tamer Özülker
Eur Arc Med Res 2021; 37: 236-243 DOI: 10.4274/eamr.galenos.2021.52533

Original Article

In Colorectal Cancer Patients, Plasma Paraoxonase (PON) Level
  • İsmayil Yılmaz
  • Müfide Nuran Akçay
  • Muhammet Fevzi Polat
  • İsmail Demiryılmaz
  • Şenol Biçer
Eur Arc Med Res 2015; 31: 65-70 DOI: 10.5222/otd.2015.065
Folfiri Plus Panitumumab as the First-Line Treatment in Patients with KRAS Wild-Type Metastatic Colorectal Cencer. A Single Center Experience
  • Çağlayan Geredeli
Eur Arc Med Res 2018; 34: 98-104 DOI: 10.5222/otd.2018.70431
A Retrospective Comparison of Preoperative MR Staging and Post-Surgical Pathology Findings in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemotherapy
  • Gülen Safiye Temel
  • Mehmet Öncü
  • Deniz Özel
  • Ramazan Albayrak
  • Bülent Aşkaroğlu
  • Yüksel Ulu
  • Betül Duran Özel
  • Fuat Özkan
Eur Arc Med Res 2016; 32: 146-153 DOI: 10.5222/otd.2016.1039